Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name HAND2-AS1
   Synonyms HAND2-AS1, DEIN, NBLA00301, UPH
   Region GRCh38_4:173527270-173659696    Sequence
   Ensembl ENSG00000237125
   RefSeq NR_136192
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name endometrioid endometrial cancer
   ICD-0-3  M8930/0
   Methods RNA-seq, qPCR, Western blot, Luciferase reporter assay, in vitro knockdown
   Sample EEC tissue, endometrial cancer cell lines (HEC1-A, HEC1-B, AN3CA, KLE, RL95-2)
   Expression Pattern down-regulated
   Function Description

HAND2-AS1 and HAND2 were frequently down-regulated in EEC tissues, especially in poor differentiated tumor tissues. Down-regulation of HAND2-AS1 and HAND2 was correlated with tumor grade, lymph node metastasis and recurrence of EEC patients. HAND2-AS1 and HAND2 were co-downregulated by promoter DNA hypermethylation in EEC.overexpression of HAND2 also inhibited migration and invasion EEC cells indicating that HAND2-AS1 and HAND2 had a concordant role in the progression of EEC. However, HAND2 was not regulated by HAND2-AS1 in EEC. Furthermore, the anti-tumorigenic effect of HAND2-AS1 was mediated by down-regulating NMU, which has an oncogenic role in EEC.

   Pubmed ID 29107108
   Year 2017
   Title Long non-coding RNA HAND2-AS1 inhibits invasion and metastasis in endometrioid endometrial carcinoma through inactivating neuromedin U.
   External Links
   Links for  HAND2-AS1 GenBank       HGNC       lncrnadb       Noncode
   Links for  endometrioid endometrial cancer Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.